Successful treatment of reactive hypoglycemia secondary to late dumping syndrome using miglitol.

We herein describe a 59-year-old woman who had undergone a total gastrectomy for gastric carcinoma and suffered from postprandial hypoglycemia characterized by a loss of consciousness and spasms. She was diagnosed with reactive hypoglycemia and treated with nutrition therapy, but the frequency and severity of the hypoglycemic episodes did not decrease. She was subsequently treated successfully with miglitol, an alpha-glucosidase inhibitor (α-GI) taken twice a day; other α-GIs (acarbose and voglibose) were not effective. In conclusion, the administration of miglitol was effective for preventing reactive hypoglycemia secondary to late dumping syndrome.

[1]  Y. Terauchi,et al.  Miglitol administered before breakfast increased plasma active glucagon-like peptide-1 (GLP-1) levels after lunch in patients with type 2 diabetes treated with sitagliptin , 2012, Acta Diabetologica.

[2]  H. Yokoyama,et al.  Comparisons of the effects of 12‐week administration of miglitol and voglibose on the responses of plasma incretins after a mixed meal in Japanese type 2 diabetic patients , 2012, Diabetes, obesity & metabolism.

[3]  Y. Terauchi,et al.  Effects of miglitol taken just before or after breakfast on plasma glucose, serum insulin, glucagon and incretin levels after lunch in men with normal glucose tolerance, impaired fasting glucose or impaired glucose tolerance , 2011, Journal of diabetes investigation.

[4]  J. Holst,et al.  Rapid Tachyphylaxis of the Glucagon-Like Peptide 1–Induced Deceleration of Gastric Emptying in Humans , 2011, Diabetes.

[5]  H. Katai,et al.  Present and future status of gastric cancer surgery. , 2011, Japanese journal of clinical oncology.

[6]  N. Tajima,et al.  Comparing the efficacy of α-glucosidase inhibitors in suppressing postprandial hyperglycemia using continuous glucose monitoring: a pilot study-the MAJOR study. , 2011, Diabetes technology & therapeutics.

[7]  K. Fukao,et al.  Single administration of alpha-glucosidase inhibitors on endothelial function and incretin secretion in diabetic patients with coronary artery disease - Juntendo University trial: effects of miglitol on endothelial vascular reactivity in type 2 diabetic patients with coronary heart disease (J-MACH) , 2010, Circulation journal : official journal of the Japanese Circulation Society.

[8]  Yuichiro Yamada,et al.  Miglitol induces prolonged and enhanced glucagon‐like peptide‐1 and reduced gastric inhibitory polypeptide responses after ingestion of a mixed meal in Japanese Type 2 diabetic patients , 2009, Diabetic medicine : a journal of the British Diabetic Association.

[9]  R. Kawamori,et al.  Miglitol suppresses the postprandial increase in interleukin 6 and enhances active glucagon-like peptide 1 secretion in viscerally obese subjects. , 2008, Metabolism: clinical and experimental.

[10]  Tomotaka Sobue,et al.  The Japanese guidelines for gastric cancer screening. , 2008, Japanese journal of clinical oncology.

[11]  J. Holst,et al.  Glucagon-like peptide-1, glucose homeostasis and diabetes. , 2008, Trends in molecular medicine.

[12]  T. Hosoi,et al.  Postprandial reactive hypoglycemia in an oldest-old patient effectively treated with low-dose acarbose. , 2006, Endocrine journal.

[13]  S. Peter.  Acarbose and Idiopathic Reactive Hypoglycemia , 2003, Hormone Research in Paediatrics.

[14]  J. Wishart,et al.  The effects of miglitol on glucagon‐like peptide‐1 secretion and appetite sensations in obese type 2 diabetics , 2002, Diabetes, obesity & metabolism.

[15]  L. Scott,et al.  Miglitol: a review of its therapeutic potential in type 2 diabetes mellitus. , 2000, Drugs.

[16]  M. Yoneda,et al.  Long‐term effect of α‐glucosidase inhibitor on late dumping syndrome , 1998 .

[17]  M. Serio,et al.  Hypoglycemia unawareness in a patient with dumping syndrome: Report of a case , 1998, Journal of endocrinological investigation.

[18]  A. Mclarty,et al.  Esophageal resection for cancer of the esophagus: long-term function and quality of life. , 1997, The Annals of thoracic surgery.

[19]  E. Brendel,et al.  Pharmacokinetics of miglitol. Absorption, distribution, metabolism, and excretion following administration to rats, dogs, and man. , 1997, Arzneimittel-Forschung.

[20]  V. Marks,et al.  Hypoglycaemia in the adult. , 1993, Bailliere's clinical endocrinology and metabolism.

[21]  D. Dunlop,et al.  Hypoglycaemia following Partial Gastrectomy , 1947 .

[22]  Y. Terauchi,et al.  Effects of pre-meal versus post-meal administration of miglitol on plasma glucagon-like peptide-1 and glucosedependent insulinotropic polypeptide levels in healthy men. , 2010, Endocrine journal.

[23]  Y. Omori,et al.  Treatment with alpha-glucosidase inhibitor for severe reactive hypoglycemia: a case report. , 2000, Endocrine journal.

[24]  M. Yoneda,et al.  Long-term effect of alpha-glucosidase inhibitor on late dumping syndrome. , 1998, Journal of gastroenterology and hepatology.

[25]  A. Masclee,et al.  The dumping syndrome. Current insights into pathophysiology, diagnosis and treatment. , 1997, Scandinavian journal of gastroenterology. Supplement.

[26]  O. Koldovský,et al.  Inhibitory mechanism of acarbose and 1-deoxynojirimycin derivatives on carbohydrases in rat small intestine. , 1987, Drugs under experimental and clinical research.